About rocuroniu m bromide
Non-depolarizing neuromuscular blocking agent
Used for
- Relaxes muscles during general anaesthesia and surgery.
- Facilitates placement of a breathing tube.
- Supports mechanical ventilation in intensive care.
Usual adult dose
Given intravenously by an anaesthesia professional; initial dose commonly 0.6 mg/kg, adjusted to the procedure and response.
Usual dose in children
Used in children under specialist supervision; initial intravenous dose commonly 0.6 mg/kg, adjusted to response.
Common side effects
- Temporary muscle weakness or prolonged paralysis
- Changes in heart rate or blood pressure
- Injection-site pain or swelling
- Allergic reactions, rarely severe
Important warnings
- Causes paralysis, including of breathing muscles; breathing support is essential.
- Use only by trained clinicians with airway and resuscitation equipment available.
- Paralysis may last longer with certain illnesses or medicines.
- Does not cause unconsciousness or relieve pain; anaesthesia is also required.
Pregnancy
Use only when clinically necessary; available human pregnancy information is limited.
Breastfeeding
Human milk information is limited; discuss timing of breastfeeding with the treating clinician.
Interactions
- Anaesthetics and magnesium may strengthen or prolong its effects.
- Some antibiotics can increase or prolong paralysis.
- Certain anticonvulsants may reduce its effect or change its duration.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.